Flen Health
Kim Vander Haegen is an experienced finance professional currently serving as the Finance, IT & Supply Chain Director at Flen Health since September 2022. Prior to this role, Kim held positions at Ackermans & van Haaren in Finance & Group Controlling from September 2019 to September 2022, and at Elia as Tax, Reporting, Treasury & IFRS Manager from July 2017 to September 2019. Kim’s earlier career includes significant experience at EY from October 2005 to July 2017, encompassing roles such as Senior Manager in Transaction Advisory Services/M&A, Senior Audit Manager, Executive, and Auditor. Educational qualifications include a Licentiaat in de handelswetenschappen from Lessius Hogeschool Antwerpen, a degree from BAB Brabant as a member of the Beroepsvereniging voor Fiscale en Boekhoudkundige Beroepen van Brabant, CFA Level 1 from the CFA Institute, and a Gegradueerde in de fiscale wetenschappen from Fiscale Hogeschool Brussel, awarded with the BNP Paribas prize.
This person is not in any teams
This person is not in any offices
Flen Health
Flen Health Live the Life you love! Flen Health believes biotech innovations can help to build a securer life for you and for every human being. Flen Health wants to improve the quality of life of people suffering from skin disorders in a responsible way, by providing added value for patients, healthcare professionals, health authorities and the environment. Flen Health was established in 2000, building on the results of wound-treatment research performed by its managing director, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health developed and commercializes a number of innovative wound and skin healing solutions. Flen Health holds an ISO 13485 certificate that covers all its operations. Thanks to the success on the Belgian market, Flen Health initiated its international expansion. This resulted in the establishment of further affiliates across Europe (in The Netherlands, Luxembourg, UK & Germany), managed by over 100 motivated employees. Flen Health products are distributed in 25 countries all over the world. Current product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel®, Flamigel®RT, Flamirins® and extracalm®. Direct customers are mainly healthcare professionals: Flaminal® Hydro/Forte indicated for all kind of wound treatments and Flamigel® RT for skin damage caused by radiotherapy. Flen Health continues to expand its activities and invites motivated and dynamic people to join. Feel welcome to visit our website for more information: